TRV GP IV, LLC
- SEC CIK
- 0001688325
- Latest filing
- Aug 7, 2026
Holdings in Q3 2022
Holdings as of Sep 30, 2022, filed Nov 3, 2022. Long positions only; changes compare share counts with Q2 2022.
- Positions
- 5
- 0 vs. Q2 2022
- Portfolio value
- $171.1M
- +$19.1M (+12.5%) vs. Q2 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| TNGXTango Therapeutics, Inc. | COM | 19,363,975 | $70.1M | 41.0% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,132,867 | $44.6M | 26.0% | 00.0% | Unchanged | History |
| RVMDRevolution Medicines, Inc. | COM | 1,419,900 | $28.0M | 16.4% | 00.0% | Unchanged | History |
| FULCFulcrum Therapeutics, Inc. | COM | 2,343,154 | $19.0M | 11.1% | 00.0% | Unchanged | History |
| DNTHDianthus Therapeutics, Inc. | COM | 6,758,204 | $9.53M | 5.6% | 00.0% | Unchanged | History |